Switzerland· 26660003
Deca-Durabolin 50 mg, Injektionslösung (i.m.)
A nandrolone product, registered in Switzerland by Aspen Pharma Schweiz GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 7 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Nandrolone is registered in 7 of 19 countries.
Countries holding a registration under ATC A14AB01 (nandrolone), each read from that country’s own register.
- This record: Switzerland
- 5 of them publish a price we can compare per daily dose
Nandrolone · ATC A14AB01
7 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
- Manufacturer
- Aspen Pharma Schweiz GmbH
- Country
- Switzerland (CH)
- ATC code
- A14AB01
- ATC class
- Nandrolone
- Defined daily dose
- 2 mg, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A14AB01
Nandrolone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd0ad3e7-6c35-45ed-92af-fe82419309e2 GET /v1/drugs/fd0ad3e7-6c35-45ed-92af-fe82419309e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about nandrolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.